MetaCap

Who Owns Kyverna Therapeutics Stock?

NASDAQ: KYTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

4.26-0.11 (-2.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
79.14%
Institutional holders
182
  • Institutions 79.1%
  • Insiders 7.7%
  • Public and other 13.2%

Who owns Kyverna Therapeutics stock?

Institutional investors own about 79.1% of Kyverna Therapeutics's shares, spread across 182 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.68% of KYTX.

The largest institutional holders are GordonMD Global Investments LP (6.86%), Gilead Sciences Inc (6.67%) and AIGH Capital Management LLC (5.90%). Together, the top 10 institutions control 41.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their KYTX positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of KYTX

Kyverna Therapeutics top institutional holders
InstitutionShares% HeldChange
GordonMD Global Investments LP4.24M6.86%0.0%
Gilead Sciences Inc4.13M6.67%0.0%
AIGH Capital Management LLC3.65M5.90%+30.6%
Blackrock Inc.3.13M5.07%+257.4%
Bain Capital Life Sciences Investors, LLC2.88M4.67%-7.2%
Deerfield Management Company, L.P2.00M3.23%0.0%
Vanguard Capital Management LLC1.90M3.07%+6.4%
State Street Corporation1.20M1.95%+22.5%
Price (T.Rowe) Associates Inc1.19M1.92%-23.7%
Geode Capital Management, LLC1.05M1.70%+0.4%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of KYTX

Kyverna Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.40M2.27%
iShares Trust-iShares Russell 2000 ETF1.11M1.79%
T. Rowe Price Health Sciences Fund, Inc.856.80K1.39%
Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF487.96K0.79%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund459.63K0.74%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund448.15K0.72%
iShares Trust-iShares Russell 2000 Value ETF353.70K0.57%
iShares Trust-iShares Biotechnology ETF294.01K0.48%
SPDR SERIES TRT-State Street SPDR S&P Kensho New Economies Composite E259.50K0.42%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund240.59K0.39%

Frequently asked questions

Who is the largest shareholder of Kyverna Therapeutics?

GordonMD Global Investments LP is the largest institutional shareholder of KYTX, owning 6.86% of shares outstanding (4.24M shares) as of its latest 13F filing.

What percentage of Kyverna Therapeutics is owned by institutions?

Institutions own about 79.1% of KYTX shares and 85.7% of the public float.

How much of Kyverna Therapeutics do insiders own?

Insiders, such as officers and directors, own about 7.68% of KYTX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related